FTC proposes changes to ophthalmology prescription laws

The Federal Trade Commission is holding a public workshop on May 18 to allow comments on its proposed update to the Ophthalmic Practice Rules, commonly known as the Eyeglass Rule, which would require ophthalmologists and optometrists to get a signed statement from patients confirming the receipt of a prescription copy. 

Advertisement

The Eyeglass Rule, which is designed to facilitate consumer choice and promote competition in the market, currently requires physicians to provide patients with a copy of their prescription immediately after an appointment. 

Prescribers cannot require the patient to buy glasses, pay an additional fee, or sign a waiver to receive the prescription. If the rule is amended, prescribers will have to keep a signed statement from patients on file for three years. 

Another proposed amendment would also allow providers to provide a digital prescription instead of a paper prescription, with patient consent, according to a March 21 press release. 

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

  • The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

Advertisement

Comments are closed.